1. Home
  2. NAAS vs TELA Comparison

NAAS vs TELA Comparison

Compare NAAS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NaaS Technology Inc.

NAAS

NaaS Technology Inc.

N/A

Current Price

$3.27

Market Cap

41.7M

ML Signal

N/A

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.73

Market Cap

41.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAAS
TELA
Founded
2019
2012
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
41.3M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
NAAS
TELA
Price
$3.27
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.00
AVG Volume (30 Days)
18.9K
71.1K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.59
EPS
N/A
N/A
Revenue
N/A
$80,275,000.00
Revenue This Year
N/A
$10.23
Revenue Next Year
N/A
$14.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.84
52 Week Low
$0.64
$0.50
52 Week High
$4.54
$2.14

Technical Indicators

Market Signals
Indicator
NAAS
TELA
Relative Strength Index (RSI) 50.46 43.43
Support Level $2.85 $0.67
Resistance Level $3.25 $0.75
Average True Range (ATR) 0.26 0.09
MACD -0.01 -0.00
Stochastic Oscillator 39.47 9.99

Price Performance

Historical Comparison
NAAS
TELA

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: